1. Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial Drye, Lea T.; Spragg, David; Devanand, Devangere P.; Frangakis, Constantine; Marano, Christopher; Meinert, Curtis L.; Mintzer, Jacobo E.; Munro, Cynthia A.; Pelton, Gregory; Pollock, Bruce G.; Porsteinsson, Anton P.; Rabins, Peter V.; Rosenberg, Paul B.; Schneider, Lon S.; Shade, David M.; Weintraub, Daniel; Yesavage, Jerome; Lyketsos, Constantine G.; CitAD Research Group 2014 Articles Long QT syndromeSerotonin uptake inhibitorsClinical trialsAlzheimer's disease--PatientsNeurosciencesMedicine